SMITHS FALLS, ON, May 14, 2015 /CNW Telbec/ - Tweed Marijuana
Inc. ("Tweed Marijuana" or "the Company") (TSXV: TWD) and wholly
owned subsidiaries Tweed Inc. (Tweed) and Tweed Farms Inc. (Tweed
Farms) continue to experience an increase in demand in the medical
marijuana market.
Tweed continues to engage with the medical community, over 6000
interactions to date. By promoting education in the medical
community, physicians feel more comfortable incorporating marijuana
in their practices, which has resulted in more Canadians choosing
Tweed as their medical marijuana supplier.
The Company announced on February
18th, 2015 that over 75,000 grams had been sold
to that point in Q5, the three-month period ended March 31st, 2015. The Company
continued to experience growth and ended Q5 with over 165,000 grams
sold.
"Incorporating strong medical outreach and education initiatives
is a top priority for Tweed. Canadian doctors will feel
increasingly confident prescribing cannabis to appropriate patients
if they receive guidance and education", said Bruce Linton, Chairman and CEO of Tweed. "We are
funding major research initiatives and creating accredited medical
education materials that will benefit hundreds of thousands of
Canadians who will use this medicine in the coming decade."
Tweed has received accreditation from the College of Family
Physicians of Canada (CFPC) for a
continuing medical education program.
Marijuana for Medical Purposes: The Essentials for Effective
Practice was recently approved up to 1.5 Mainpro-M1 credits. The M1
designation indicates the program has demonstrated a commitment to
quality educational programming and has undergone a peer-review
process to ensure all content is relevant to family physicians.
More than 20,000 family physicians across Canada require Mainpro credits to maintain
their CFPC membership.
Tweed will engage with the physician community in the coming
weeks to outline how they can participate in this educational
opportunity.
"We position our brand to be approachable to individual
customers, the emphasis we place on medical outreach and education
efforts extends this dialogue to include physicians. We believe
we're the first Licensed Producer to offer a nationally accredited
program by the CFPC, an accomplishment that will enhance our
reputation within the healthcare community," said Bruce Linton.
On Monday May 11th,
Tweed joined industry partners announcing start-up funding for a
research framework to allow physicians in Quebec to prescribe cannabis to their
patients. Less than 3% of the market currently resides in
Quebec because a clear framework
did not exist in the Province. Tweed has since launched a bilingual
website, offering the same rich customer experience in English and
French.
Tweed has enhanced the Company's diverse strain selection by
adding three new strains containing higher levels of the
non-psychoactive component Cannabidiol (CBD). CBD-rich strains are
sought by many patients and doctors because they do not have the
same psychoactive effects of strains with higher levels of THC, the
more common active ingredient associated with marijuana.
Here's to Future Growth.
About Tweed Marijuana
Tweed Marijuana Inc. is Canada's first publicly traded medical
marijuana company and the first geographically diversified producer
with dual licenses under the Marihuana for Medical Purposes
Regulations.
Through its wholly owned subsidiaries, Tweed Inc. and Tweed
Farms Inc., Tweed Marijuana Inc. operates two state-of-the-art
production facilities in Ontario
and distributes marijuana across the country to Canadian patients
managing a host of medical conditions.
Tweed is dedicated to educating healthcare practitioners,
providing consistent access to high quality medication, and
furthering the public's understanding of how marijuana is used for
medical purposes.
Notice Regarding Forward Looking Statements:
This news release contains forward-looking statements. Often,
but not always, forward-looking statements can be identified by the
use of words such as "plans", "expects" or "does not expect", "is
expected", "estimates", "intends", "anticipates" or "does not
anticipate", or "believes", or variations of such words and phrases
or state that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance or achievements of the Tweed Marijuana Inc. or Tweed
Inc. to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements. Examples of such statements include:
(A) predictions of future demand; (B) plans to increase capital
expenditure and construction related expenses; (C) anticipated
production yields; (D) completion of construction and availability
of new production rooms; and (E) forecasted available product
selection. Actual results and developments are likely to differ,
and may differ materially, from those expressed or implied by the
forward-looking statements contained in this news release. Such
forward-looking statements are based on a number of assumptions
which may prove to be incorrect, including, but not limited to: the
ability to obtain any necessary financing; the economy generally;
the yield from Tweed's marijuana growing operations; consumer
interest in products; competition; regulation and anticipated and
unanticipated costs and delays. Although Tweed Marijuana Inc. has
attempted to identify important factors that could cause actual
actions, events or results to differ materially from those
described in forward-looking statements, there may be other factors
that cause actions, events or results not to be as anticipated,
estimated or intended. Readers should not place undue reliance on
forward-looking statements. The factors identified above are not
intended to represent a complete list of the factors that could
affect Tweed Marijuana Inc. or Tweed Inc. Additional factors are
noted under "Part IV - Description of Risk Factors Associated with
the Acquisition" in the Filing Statement of Tweed Marijuana Inc.
dated as of June 30, 2014 and available at www.SEDAR.com. The
forward-looking statements included in this news release are made
as of the date of this news release and Tweed Marijuana Inc. does
not undertake an obligation to publicly update such forward-looking
statements to reflect new information, subsequent events or
otherwise unless required by applicable securities legislation.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
SOURCE Tweed Marijuana Inc.